Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sahlgrenska University Hospital Cardiomyopathy Project: Mapping and Diagnosis of Cardiomyopathies to Enable Early and Specific Treatment

NCT03527342 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT03527342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03527342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sahlgrenska University Hospital Cardiomyopathy Project: Mapping and Diagnosis of Cardiomyopathies to Enable Early and Specific Treatment
Lead sponsor
Göteborg University
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 1, 2018
Completion date
January 31, 2029
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis; heart (manifestation), arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathies, giant cell myocarditis, hypertrophic cardiomyopathy, myocarditis, restrictive cardiomyopathy, sarcoidosis with myocarditis